Loading…
← CockpitCompetitor Analysis › 603155.SS Xinyaqiang Silicon Chemistry Co., Ltd. Class AOpen in the cockpit ↗

Xinyaqiang Silicon Chemistry Co., Ltd. Class A603155.SSCompetitor analysis, valuation and peers

China · CNY·Materials›Chemicals: Major Diversified

Chinese producer of organosilicon/silicone chemical products (name-derived; specifics not fully confirmed).

Momentum neutral 42
Mkt cap
$798M
US dollars, full cap
Free float
27%
of shares outstanding
$/day
$20.9M
20-day average traded
Fwd P/E
37.4×
forward earnings
ROIC−WACC
-0.0 pp
WACC 8.7%
Hurdle
+19 pp
Req g minus delivered
Next earnings
161 days
28 Apr 2027
Close · CNYCN¥11.45
1D-1.8%
1W-6.3%
1M-27.2%
3M-16.2%
6M-14.9%
YTD-3.1%
1Y+3.6%
ATR %6.6%
52w lowhigh46.4% off high

What Xinyaqiang Silicon Chemistry does

Chinese producer of organosilicon/silicone chemical products (name-derived; specifics not fully confirmed).

Where it sits in the supply chain

  • Materials
  • Specialty chemicals
  • Silicone chemicals

Moat: none

Headquarters: China · Employees: 398

Xinyaqiang Silicon Chemistry at a glance

Size Xinyaqiang Silicon Chemistry (603155.SS) is a China Materials company (Chemicals: Major Diversified) with a market value of $798M, the 2593rd largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥11.45 on 18 Nov 2026.

Performance Over six months the shares fell 14.9%, against -23.1% for the median peer and -20.0% for the China market (cap-weighted) — 7th highest of 21 in its peer set.

Growth Revenue grew 24.9% over the last twelve months (peer median +8.4%); the operating margin is 11.6% (peer median 10.4%).

Valuation It trades at 37.4× forward earnings against a peer median of 19.5× (2nd most expensive of 15).

Price implies For today's price to make sense, revenue must grow about 23% a year for seven years (Req g). Recent delivered growth is +4%, so the hurdle is +19 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 0.0 points below its cost of capital (8.7% WACC).

Next results Next results expected around 28 Apr 2027 (exchange calendar; dates can move).

Relative performance

7510012515021 May 202621 Aug 202618 Nov 2026603155.SS 84Peer median 77
Six months, rebased to 100: Xinyaqiang Silicon Chemistry against the median of its 20 peers (local-currency closes).

Xinyaqiang Silicon Chemistry financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥760MCN¥589MCN¥714MCN¥667MCN¥1.13B
Revenue growth—-18%+7%-41%—
Gross profitCN¥199MCN¥106MCN¥129MCN¥144MCN¥333M
EBITDAn/aCN¥87.4MCN¥120MCN¥126MCN¥323M
Net incomeCN¥101MCN¥81.9MCN¥114MCN¥123MCN¥302M
Free cash flowCN¥121MCN¥51.8MCN¥186MCN¥166MCN¥110M
Capital expenditureCN¥41.9MCN¥30.4MCN¥18.1MCN¥50.7MCN¥230M
Total debtCN¥108MCN¥40.8MCN¥118MCN¥110MCN¥201M

Quarterly statements and history in the cockpit →

Xinyaqiang Silicon Chemistry competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%-25%0%+25%-20%0%4471301393688359497541896053666031815234300121688237300641300530RPEL300082002274603360000635214370301206JUBLINGREA603155.SS6-month return →1-month return →
Up and to the right = strong over both horizons. Xinyaqiang Silicon Chemistry is the large dot.

Fundamentals: revenue growth against valuation

0%+10%+20%+30%0×100×200×4471301393497541896053665234688237300082002274603360JUBLINGREA603155.SSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Xinyaqiang Silicon Chemistry is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%4471497541895234300121688237300641002274603360214370JUBLINGREA603155.SSGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Xinyaqiang Silicon Chemistry is the large dot.

Xinyaqiang Silicon Chemistry competitors and peer comparison

How Xinyaqiang Silicon Chemistry compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Xinyaqiang Silicon Chemistry against its 20 peers (data as of 18 Nov 2026)
Measure603155.SSPeer medianRank in peer set
1-month return-27.2%-12.0%3rd lowest of 21
6-month return-14.9%-23.1%7th highest of 21
Distance from 52-week high-46.4%-36.5%8th lowest of 21
Revenue growth (TTM)+24.9%+8.4%3rd highest of 21
Operating margin11.6%10.4%10th highest of 21
Forward P/E37.4×19.5×2nd most expensive of 15
Growth the price implies (Req g, 7 yrs)22.5%8.5%5th most demanding of 12
Growth delivered (Del g)+3.9%+8.3%5th lowest of 12
Hurdle (Req g minus delivered)+18.6 pp-4.5 pp3rd most demanding of 12
ROIC minus cost of capital-0.0 pp-2.1 pp9th highest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Xinyaqiang Silicon Chemistry 603155.SSChina$798M-15%+25%12%37.4×22.5%+3.9%
Sanyo Chemical Industries 4471.TJapan$794M+8%+8%11%9.6×-7.2%-2.5%
Suzhou Highfine Biotech 301393.SZChina$786M-15%+36%17%29.4×n/an/a
Guangzhou Sanfu Newmaterials Technology 688359.SSChina$832M-54%+8%-7%n/an/an/a
JCU 4975.TJapan$744M-34%+5%39%13.4×5.5%+7.0%
KH Neochem 4189.TJapan$738M+20%-6%12%11.8×-5.0%+8.3%
Jiangxi Hungpai New Material 605366.SSChina$736M-46%+9%-11%211.7×n/an/a
Zhejiang Huangma Technology 603181.SSChina$891M-33%+7%17%13.8×n/an/a
Daxin Materials 5234.TWTaiwan$705M-39%+12%20%15.8×15.9%+1.5%
Shandong Yanggu Huatai Chemical 300121.SZChina$703M-16%+11%8%17.5×4.7%+12.1%
Hubei Chaozhuo Aviation Technology 688237.SSChina$697M-5%-1%1%37.3×43.1%+26.0%
Jiangsu Zhengdan Chemical Industry 300641.SZChina$914M-29%-30%17%n/a7.1%+11.6%
Hunan Lead Power Technology 300530.SZChina$691M+12%+16%-61%n/an/an/a
Raghav Productivity Enhancers RPEL.NSIndia$942M+109%+38%28%n/an/an/a
Liaoning Oxiranchem,Inc 300082.SZChina$673M-45%+4%0%33.0×n/an/a
Jiansu Huachang Chemical 002274.SZChina$663M-25%+9%-3%5.6×23.2%+1.3%
Dalian Bio-Chem 603360.SSChina$971M-54%0%16%21.7×8.5%+18.4%
Ningxia Yinglite Chemicals 000635.SZChina$650M+35%-14%-48%n/an/an/a
Caregen 214370.KSSouth Korea$982M-74%-2%20%21.5×36.8%+3.8%
Shandong Sanyuan Biotechnology 301206.SZChina$644M-21%+15%4%n/an/an/a
Jubilant Ingrevia JUBLINGREA.NSIndia$1.00B-19%+15%10%21.6×28.0%+44.9%

Questions

Which companies are Xinyaqiang Silicon Chemistry's closest peers?
The cockpit's peer set: Sanyo Chemical Industries (4471.T), Suzhou Highfine Biotech (301393.SZ), Guangzhou Sanfu Newmaterials Technology (688359.SS), JCU (4975.T), KH Neochem (4189.T), Jiangxi Hungpai New Material (605366.SS), Zhejiang Huangma Technology (603181.SS), Daxin Materials (5234.TW).
Is Xinyaqiang Silicon Chemistry expensive compared with its peers?
On forward p/e it trades at 37.4× against a peer median of 19.5×, 2nd most expensive of 15 in its peer set. For today's price to make sense, revenue must grow about 23% a year for seven years (Req g). Recent delivered growth is +4%, so the hurdle is +19 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Xinyaqiang Silicon Chemistry stock performed?
Over six months to 18 Nov 2026 the shares returned -14.9% against -23.1% for the median peer; over one year +3.6%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.